181 related articles for article (PubMed ID: 26714983)
1. Anti-inflammatory and lymphangiogenetic effects of low-level laser therapy on lymphedema in an experimental mouse tail model.
Jang DH; Song DH; Chang EJ; Jeon JY
Lasers Med Sci; 2016 Feb; 31(2):289-96. PubMed ID: 26714983
[TBL] [Abstract][Full Text] [Related]
2. Lymphangiogenesis in chronic inflammation in the testis.
Hirai S; Naito M; Terayama H; Qu N; Kuerban M; Musha M; Itoh M
Andrology; 2013 Jan; 1(1):147-54. PubMed ID: 23258644
[TBL] [Abstract][Full Text] [Related]
3. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis.
Cheung L; Han J; Beilhack A; Joshi S; Wilburn P; Dua A; An A; Rockson SG
BioDrugs; 2006; 20(6):363-70. PubMed ID: 17176124
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronidase treatment of acute lymphedema in a mouse tail model.
Jeong HJ; Roh KH; Kim GC; Kim YO; Lee JH; Lee MJ; Sim YJ
Lymphology; 2013 Dec; 46(4):160-72. PubMed ID: 25141459
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization.
Jin DP; An A; Liu J; Nakamura K; Rockson SG
Lymphat Res Biol; 2009; 7(1):47-57. PubMed ID: 19302023
[TBL] [Abstract][Full Text] [Related]
7. The resolution of lymphedema by interstitial flow in the mouse tail skin.
Uzarski J; Drelles MB; Gibbs SE; Ongstad EL; Goral JC; McKeown KK; Raehl AM; Roberts MA; Pytowski B; Smith MR; Goldman J
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1326-34. PubMed ID: 18203849
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.
Kubo M; Li TS; Kamota T; Ohshima M; Shirasawa B; Hamano K
J Vasc Surg; 2010 Aug; 52(2):429-34. PubMed ID: 20670777
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphoedema.
Serizawa F; Ito K; Matsubara M; Sato A; Shimokawa H; Satomi S
Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):254-60. PubMed ID: 21454105
[TBL] [Abstract][Full Text] [Related]
11. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model.
Yoshida S; Hamuy R; Hamada Y; Yoshimoto H; Hirano A; Akita S
Regen Med; 2015; 10(5):549-62. PubMed ID: 26237700
[TBL] [Abstract][Full Text] [Related]
12. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
[TBL] [Abstract][Full Text] [Related]
13. Regulation of inflammation and fibrosis by macrophages in lymphedema.
Ghanta S; Cuzzone DA; Torrisi JS; Albano NJ; Joseph WJ; Savetsky IL; Gardenier JC; Chang D; Zampell JC; Mehrara BJ
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1065-77. PubMed ID: 25724493
[TBL] [Abstract][Full Text] [Related]
14. Adipose-Derived Stem Cells Promote Intussusceptive Lymphangiogenesis by Restricting Dermal Fibrosis in Irradiated Tissue of Mice.
Ogino R; Hayashida K; Yamakawa S; Morita E
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485955
[TBL] [Abstract][Full Text] [Related]
15. Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema.
Kashiwagi S; Hosono K; Suzuki T; Takeda A; Uchinuma E; Majima M
Lab Invest; 2011 Sep; 91(9):1314-25. PubMed ID: 21577211
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice.
Nakamura K; Radhakrishnan K; Wong YM; Rockson SG
PLoS One; 2009 Dec; 4(12):e8380. PubMed ID: 20027220
[TBL] [Abstract][Full Text] [Related]
17. Growth factor therapy and lymph node graft for lymphedema.
Tervala TV; Hartiala P; Tammela T; Visuri MT; Ylä-Herttuala S; Alitalo K; Saarikko AM
J Surg Res; 2015 Jun; 196(1):200-7. PubMed ID: 25777822
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
19. Excess Lymphangiogenesis Cooperatively Induced by Macrophages and CD4(+) T Cells Drives the Pathogenesis of Lymphedema.
Ogata F; Fujiu K; Matsumoto S; Nakayama Y; Shibata M; Oike Y; Koshima I; Watabe T; Nagai R; Manabe I
J Invest Dermatol; 2016 Mar; 136(3):706-714. PubMed ID: 27015456
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
Yoon YS; Murayama T; Gravereaux E; Tkebuchava T; Silver M; Curry C; Wecker A; Kirchmair R; Hu CS; Kearney M; Ashare A; Jackson DG; Kubo H; Isner JM; Losordo DW
J Clin Invest; 2003 Mar; 111(5):717-25. PubMed ID: 12618526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
